Resultados de la búsqueda 401-410 of 16732 for Gallbladder Cancer

  1. Stage 4 (metastatic) colon cancer - Médicos y departamentos - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  2. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  3. Stage 4 (metastatic) colon cancer - Médicos y departamentos - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  4. Stage 4 (metastatic) colon cancer - Médicos y departamentos - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  5. Stage 4 (metastatic) colon cancer - Médicos y departamentos - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  6. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  7. Stage 4 (metastatic) colon cancer - Médicos y departamentos - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  8. Oncología (médica) - Ensayos clínicos

    Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung cancer. Venetoclax is FDA approved for the ...

  9. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...